Total Funding
88
73
Total FundingVenture - Series Unknown raised
Growth Score 88 in past quarter
-1 pts
Heat Score 73 in past quarter
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
17337
Ancilia Biosciences offers bacterial therapeutics that address the microbiome's viral components.
- Alexandra Sakatos: Co-Founder & CEO
- Matthew Cummings: Co-Founder and Scientific AdvisorPast Role: Innovation Forum, Business Development Associate
About the Company
Ancilia Biosciences develops engineered bacterial therapies to treat diseases linked to the microbiome. It provides and develops novel bacterial therapies that target the viral components of the microbiome to address chronic diseases across immunology and oncology indications.
Women Founded